Medical diagnostics company Check-Cap announced it has filed for CE Mark registration for C-Scan, an ingestible capsule for preparation-free colorectal cancer screening. C-Scan uses low-dose X-ray and ...
Patients who underwent the procedure, as part of the 2019 U.S. pilot study, were significantly more likely to recommend C-Scan test compared to colonoscopy ISFIYA, Israel, Nov. 22, 2021 /PRNewswire/ - ...
ISFIYA, Israel, March 15, 2021 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback